Alpha Centric Advisors LLC Ideaya Biosciences, Inc. Transaction History

Alpha Centric Advisors LLC

  • $118 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Mar 09, 2022
SELL
$17.76 - $24.83 $177,600 - $248,299
-10,000 Closed
0 $0
Q1 2021

Mar 09, 2022
SELL
$13.48 - $23.77 $33,700 - $59,425
-2,500 Reduced 20.0%
10,000 $235,000
Q4 2020

Mar 11, 2022
BUY
$12.17 - $17.52 $133,870 - $192,720
11,000 Added 733.33%
12,500 $175,000
Q2 2020

Mar 11, 2022
BUY
$3.59 - $18.57 $5,385 - $27,855
1,500 New
1,500 $21,000

Others Institutions Holding IDYA

# of Institutions
216
Shares Held
80.8M
Call Options Held
69K
Put Options Held
20K
View Full List

About IDEAYA Biosciences, Inc.

IDYA Quotes by TradingView
  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.29B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email